Targeting the LRP5 Pathway Improves Bone Properties in a Mouse Model of Osteogenesis Imperfecta
Year: 2014
Type: article
Abstract: The cell surface receptor low-density lipoprotein receptor-related protein 5 (LRP5) is a key regulator of bone mass and bone strength. Heterozygous missense mutations in LRP5 cause autosomal dominant high bone mass (HBM) in humans by reducing binding to LRP5 by endogenous inhibitors, such as sclerostin (SOST). Mice heterozygous for a knockin allele (Lrp5(p.A214V) ) that is orthologous to a human HBM-causing mutation have increased bone mass and strength. Osteogenesis imperfecta (OI) is a skeletal fragility disorder predominantly caused by mutations that affect type I collagen. We tested whether the LRP5 pathway can be used to improve bone properties in animal models of OI. First, we mated Lrp5(+/p.A214V) mice to Col1a2(+/p.G610C) mice, which model human type IV OI. We found that Col1a2(+/p.G610C) ;Lrp5(+/p.A214V) offspring had significantly increased bone mass and strength compared to Col1a2(+/p.G610C) ;Lrp5(+/+) littermates. The improved bone properties were not a result of altered mRNA expression of type I collagen or its chaperones, nor were they due to changes in mutant type I collagen secretion. Second, we treated Col1a2(+/p.G610C) mice with a monoclonal antibody that inhibits sclerostin activity (Scl-Ab). We found that antibody-treated mice had significantly increased bone mass and strength compared to vehicle-treated littermates. These findings indicate increasing bone formation, even without altering bone collagen composition, may benefit patients with OI.
DOI: 10.1002/jbmr.2198
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: bronze
Awards: COBRE for Skeletal Health and Repair, Does increasing bone mass also increase bone strength in mouse models of OI?, G3120283113, Collagen Diversity and Pathobiology in Skeletal Tissues, Targeting the Lrp5 Pathway To Increase Bone Strength In Osteogenesis Imperfecta, Collagen Cross-linking in Skeletal Aging and Disease, G6847447808, Pathogenesis of Novel Forms of Osteogenesis Imperfecta, G7450316474, COLLAGEN CROSS-LINKING IN SKELETAL AGING AND DISEASE, G9000241741, Lrp5 and Lrp6 signaling in bone mechanotransduction and metabolism
OpenAlex ID: W1571403857
